SCHEMBL8134361

SCHEMBL8134361

CC(C)/C=C/C(=O)Nc1ccc(F)cc1F

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.66
▸ CYP2C19 P33261 2/20 0.66
▸ EGFR P00533 1/20 0.59
▸ HTT P42858 2/20 0.53
▸ RECQL P46063 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ PKM P14618 1/20 0.50
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ GAA P10253 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12512971 0.83 ALDH1A1 (0.71) ALDH1A1CYP2C19EGFRHTTRECQL
SCHEMBL6895432 0.80 ALDH1A1 (1.00) ALDH1A1CYP2C19EGFRHTTPOLB
SCHEMBL6895438 0.80 ALDH1A1 (1.00) ALDH1A1CYP2C19EGFRHTTPOLB
SCHEMBL29505769 0.76 ALDH1A1 (0.66) ALDH1A1CYP2C19EGFRHTTPOLB
SCHEMBL8549226 0.76 ALDH1A1 (0.66) ALDH1A1CYP2C19EGFRHTTPOLB
SCHEMBL12780368 0.76 RECQL (0.61) ALDH1A1CYP2C19HTTRECQLPOLB
SCHEMBL1966603 0.75 EGFR (1.00) ALDH1A1CYP2C19EGFRHTTKMT2A
SCHEMBL1966601 0.75 EGFR (1.00) ALDH1A1CYP2C19EGFRHTTKMT2A
SCHEMBL25078286 0.74 ALDH1A1 (0.63) ALDH1A1CYP2C19EGFRHTTPOLB
SCHEMBL6694651 0.73 SMN1; SMN2 (0.67) ALDH1A1CYP2C19HTTRECQLPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178092-A1 HIV-1 Protease Inhibitors UNIVERSITY OF MARYLAND, COLLEGE PARK 2011-07-21 — — US disclosed
WO-2008118849-A2 HIV-1 PROTEASE INHIBITORS UNIVERSITY OF MASSACHUSETTS (US) 2008-10-02 — — WO disclosed
WO-2007002172-A2 HIV-1 PROTEASE INHIBITORS UNIVERSITY OF MASSACHUSETTS (US) 2007-01-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178092-A1 HIV-1 Protease Inhibitors SERPINB1, PRSS1, TMPRSS4 ALDH1A1 2716/4885CYP2C19 3360/4885EGFR 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback